Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis
NCT00036179
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
75
Enrollment
INDUSTRY
Sponsor class
Conditions
Candidiasis
Interventions
DRUG:
FK463
Sponsor
Astellas Pharma Inc